Dr. Steven Hu serves as CTO and CBO of Asymchem and is responsible for new technology development and business development. Before joining Asymchem, Dr. Hu was the CTO of Everest Medicines, where he was responsible for CMC, supply chain, and technical operations. He grew the team from inception and was responsible for the in-license of eight drugs. Before joining Everest, he was the senior director and head of CMC at Roche Pharm Research and Development Shanghai, heading process research and synthesis, analytical, preformulation, and formulation development. Prior to Roche, he was the director of new product development of GSK China R&D, overseeing the management of the entire drug product development life cycle from formulation development and optimization, process development, and scale-up to technology transfer and commercial manufacturing. Dr. Hu obtained his Ph.D. in chemical engineering from Brown University and conducted postdoctoral research at MIT.